Search Results
Slidesets
Moving forward to 90-90-90: Analysis of a cohort of recently-diagnosed patients in a tertiary hospital in Buenos Aires, Argentina - Dr. Barletta
Presented at:
Andean Pacific Workshop on HIV & Hepatitis 2017
Slidesets
In vivo evaluation of anti-HBV CRISPR/Cas9 therapy in the FRG mouse- Dr. K. Jerome
Presented at:
HEP DART 2017
Slidesets
Lamivudine plus either Atazanavir/ritonavir, Darunavir/ritonavir or Dolutegravir as switch strategies in HIV-positive, virologically-suppressed patients: a comparison - Alberto Borghetti
Presented at:
European HIV Clinical Forum 2016
Slidesets
Cross-resistance to integrase strand transfer inhibitors (INSTIs) in 23 multiexperienced Mexican patients failing to raltegravir - Aurelio Orta-Reséndiz, MD, MSc
Presented at:
Global HIV Clinical Forum 2016
Slidesets
Drug-drug Interactions - C. Marzolini, PharmaD, PhD.pptx
Presented at:
COVID-19 Clinical Forum for Pharmacists and Nurses 2023
Slidesets
Harmony Garges - ViiV Pipeline Overview
Presented at:
European Meeting on HIV & Hepatitis 2021
Slidesets
Epidemic of Acute HCV: What Have We Learned?- Chien-Ching Hung, MD, PhD
Presented at:
APACC 2019
Slidesets
Chinese Series 23_Update on the Long-Acting Antivirals for Treatment_Jean-Michel Molina.pdf
Presented at:
Chinese Series on Treatment Strategies 2023
Slidesets
Achieving Health Equity Through Hepatitis Elimination - John Ward
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020